Generation and Characterization of a Defined Mutant of <i>Streptococcus suis</i> Lacking Suilysin
Andrew G. Allen(University of Cambridge), Duncan J. Maskell(University of Cambridge), Steven Bolitho(University of Cambridge), Sarah Eastty(The Pirbright Institute), Clare Bryant(University of Cambridge), Helen Riches(The Pirbright Institute), Jeremy Morgan(The Pirbright Institute), Philip N. Ward(The Pirbright Institute), Shahid A. Khan(Imperial College London), James A. Leigh(Lions Eye Institute), Heather Lindsay(University of British Columbia)
Cited by 85
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
|Nucleic Acids Research|2017|1.7k
Cholangiocarcinoma
|The Lancet|2005|1.1k
Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study
|The Lancet Infectious Diseases|2011|929